Ocumension Therapeutics (FRA:5DG)
Germany · Delayed Price · Currency is EUR 0.8750
+0.0250 (2.94%)
Last updated: Nov 27, 2025, 10:30 AM CET
Ocumension Therapeutics Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
Net Income | -249.25 | -268.27 | -379.79 | -402.64 | -259.99 | -2,265 | Upgrade |
Depreciation & Amortization | 123.79 | 88.61 | 57.54 | 40.46 | 13.9 | 4.57 | Upgrade |
Other Amortization | - | - | - | - | - | 0.08 | Upgrade |
Asset Writedown & Restructuring Costs | - | - | -3.18 | 3.18 | - | - | Upgrade |
Loss (Gain) From Sale of Investments | -1.75 | -0.29 | -1.16 | -1.25 | -125.78 | -7.63 | Upgrade |
Loss (Gain) on Equity Investments | - | - | - | - | 13.33 | - | Upgrade |
Stock-Based Compensation | 58.38 | 84.63 | 139.73 | 218.79 | 188.12 | 293.59 | Upgrade |
Provision & Write-off of Bad Debts | 0.36 | 0.65 | 0.35 | 0.68 | - | - | Upgrade |
Other Operating Activities | -12.31 | -22.34 | -24.57 | -47 | 9.07 | 1,784 | Upgrade |
Change in Accounts Receivable | -32.31 | -38.93 | -7.65 | -33.28 | -31.15 | -28.14 | Upgrade |
Change in Inventory | 12.4 | -13.05 | -13 | -19.11 | -1.97 | -2.77 | Upgrade |
Change in Accounts Payable | -60.93 | -11.34 | 49.57 | 34.42 | -2.39 | 8.59 | Upgrade |
Change in Unearned Revenue | 0.69 | 1.5 | - | 30.09 | - | - | Upgrade |
Change in Other Net Operating Assets | - | - | 4.25 | -25 | - | - | Upgrade |
Operating Cash Flow | -160.92 | -178.83 | -177.93 | -200.66 | -196.85 | -212.57 | Upgrade |
Capital Expenditures | -34.15 | -47.1 | -80.91 | -115.81 | -195.37 | -50.17 | Upgrade |
Cash Acquisitions | - | - | - | - | - | -16.9 | Upgrade |
Sale (Purchase) of Intangibles | -198.4 | -183.05 | -280.96 | -194.19 | -469.44 | -254.44 | Upgrade |
Investment in Securities | 30.51 | 470.46 | 53.22 | 522.86 | -697.79 | 967.49 | Upgrade |
Other Investing Activities | 27.37 | 35.6 | 48.86 | 16.29 | 17.31 | -16.28 | Upgrade |
Investing Cash Flow | -174.67 | 275.91 | -259.78 | 229.15 | -1,345 | 629.7 | Upgrade |
Long-Term Debt Issued | - | 46.55 | 120 | - | - | - | Upgrade |
Long-Term Debt Repaid | - | -163.5 | -14.25 | -9.15 | -3.82 | -1.38 | Upgrade |
Total Debt Repaid | -16.64 | -163.5 | -14.25 | -9.15 | -3.82 | -1.38 | Upgrade |
Net Debt Issued (Repaid) | 37.11 | -116.95 | 105.75 | -9.15 | -3.82 | -1.38 | Upgrade |
Issuance of Common Stock | - | 0.98 | 5.6 | 12.72 | 684.73 | 1,611 | Upgrade |
Repurchase of Common Stock | -105.85 | -95.57 | -1.46 | -11 | -1.39 | - | Upgrade |
Other Financing Activities | -1.25 | -2.25 | -1.22 | -1.79 | -10.68 | -82.4 | Upgrade |
Financing Cash Flow | -69.99 | -213.79 | 108.66 | -9.22 | 668.85 | 1,527 | Upgrade |
Foreign Exchange Rate Adjustments | 0.73 | 3.07 | 1.84 | 25.56 | -35.81 | -102.57 | Upgrade |
Net Cash Flow | -404.85 | -113.63 | -327.21 | 44.83 | -909.1 | 1,842 | Upgrade |
Free Cash Flow | -195.07 | -225.92 | -258.84 | -316.47 | -392.22 | -262.74 | Upgrade |
Free Cash Flow Margin | -35.88% | -54.14% | -105.06% | -199.09% | -698.57% | -2006.27% | Upgrade |
Free Cash Flow Per Share | -0.26 | -0.33 | -0.40 | -0.50 | -0.65 | -0.87 | Upgrade |
Cash Interest Paid | 1.25 | 2.25 | 1.22 | 1.79 | 0.57 | 0.06 | Upgrade |
Cash Income Tax Paid | 1.17 | 0.32 | -0.03 | 0.41 | - | - | Upgrade |
Levered Free Cash Flow | -315.62 | -344.38 | -480.3 | -404.46 | -580.44 | -274.65 | Upgrade |
Unlevered Free Cash Flow | -314.89 | -343.03 | -479.47 | -403.33 | -580.09 | -274.62 | Upgrade |
Change in Working Capital | -80.14 | -61.82 | 33.15 | -12.88 | -35.5 | -22.31 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.